Showing 1,281 - 1,300 results of 230,677 for search '(( 5 ((non decrease) OR (point decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 1.79s Refine Results
  1. 1281

    Flow diagram of study participants. by Soo Hyeon Cho (19797394)

    Published 2024
    “…This observed decrease was associated with a reduction in the prevalence of conventional risk factors but not with SARS-CoV-2 infection or vaccination. …”
  2. 1282
  3. 1283
  4. 1284
  5. 1285
  6. 1286
  7. 1287
  8. 1288
  9. 1289
  10. 1290

    IFNα-treatment of MDDCs decreases the proportion of PF74-dependent luciferase activity that can be measured following EURT assay. by Claire Da Silva Santos (3186570)

    Published 2016
    “…B) The graph present individual donors (n = 8 for MDDCs and 4 independent experiments for HeLaP4 cells) that were used in the left panel, with a focus on the decrease in the percentage of PF74-dependent activity measured following incubation with IFNα. …”
  11. 1291
  12. 1292

    Supplementary Material for: 3,4-Methylenedioxymethamphetamine (Ecstasy) Decreases Inflammation and Airway Reactivity in a Murine Model of Asthma by Stankevicius D. (4130146)

    Published 2012
    “…We also showed that MDMA decreased expression of both Th2-like cytokines (IL-4, IL-5 and IL-10) and adhesion molecules (L-selectin). …”
  13. 1293
  14. 1294
  15. 1295

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
  16. 1296
  17. 1297
  18. 1298
  19. 1299
  20. 1300

    <i>Trans ε</i> viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model by Martial Caillaud (6383672)

    Published 2019
    “…Here, effects of this stilbenoid were evaluated in transgenic APPswePS1dE9 mice. We report that <i>trans ε</i>-viniferin could go through the blood brain barrier, reduces size and density of amyloid deposits and decreases reactivity of astrocytes and microglia, after a weekly intraperitoneal injection at 10 mg/kg from 3 to 6 months of age.…”